Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Zevra Therapeutics, Inc. shareholders
As of Jun 30, 2026, 152 institutions reported holding Zevra Therapeutics, Inc., 78.5% of its shares. Largest: BlackRock, Fidelity and Woodline Partners LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Zevra Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 5.11M | 8.6% | +652K | Aug 7, 2026 |
| Fidelity | 4.92M | 8.3% | +1.7M | Aug 13, 2026 |
| Woodline Partners LP | 4.79M | 8.1% | +1.33M | Aug 14, 2026 |
| Vanguard | 3.6M | 6.1% | +245K | Aug 13, 2026 |
| Nantahala Capital Management, LLC | 3.59M | 6.1% | +1.07M | Aug 19, 2026 |
| State Street | 1.68M | 2.8% | +120K | Aug 7, 2026 |
| Geode Capital | 1.54M | 2.6% | +169K | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 1.31M | 2.2% | +460K | Aug 14, 2026 |
| Qube Research & Technologies Ltd | 1.24M | 2.1% | +399K | Aug 14, 2026 |
| Morgan Stanley | 1.2M | 2.0% | +11,613 | Aug 13, 2026 |